Published in Hypertension on January 29, 1986
Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. Circulation (1998) 1.77
Cardiac abnormalities in young women with anorexia nervosa. Br Heart J (1994) 1.17
Association of left ventricular hypertrophy with incident hypertension: the multi-ethnic study of atherosclerosis. Am J Epidemiol (2011) 0.86
Relationship between left ventricular hypertrophy, hypertensive retinopathy, microalbuminuria and echocardiographic modalities in newly diagnosed hypertensive patients. Int J Cardiovasc Imaging (2010) 0.84
Trpm4 gene invalidation leads to cardiac hypertrophy and electrophysiological alterations. PLoS One (2014) 0.83
Effects of atenolol vs diltiazem on the haemodynamic effects of an inhaled beta 2-adrenoceptor agonist. Br J Clin Pharmacol (1989) 0.75
Phylloquinone Intake Is Associated with Cardiac Structure and Function in Adolescents. J Nutr (2017) 0.75
Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol (1986) 18.40
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA (2000) 12.27
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation (1977) 9.70
Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet (1996) 7.84
Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol (1992) 6.51
Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA (2000) 6.10
Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med (1991) 6.08
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet (2000) 5.42
Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med (1972) 4.80
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens (1996) 4.66
Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol (1992) 4.65
How common is white coat hypertension? JAMA (1988) 4.42
Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension (1995) 4.35
Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol (1989) 4.27
The relationship between 'job strain,' workplace diastolic blood pressure, and left ventricular mass index. Results of a case-control study. JAMA (1990) 4.00
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med (1991) 3.86
Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. Circulation (1999) 3.82
Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med (1972) 3.73
Detection and treatment of hypertension at the work site. N Engl J Med (1975) 3.43
Renal function during antihypertensive treatment. Lancet (1995) 3.33
Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation (1987) 3.16
The association between birthplace and mortality from cardiovascular causes among black and white residents of New York City. N Engl J Med (1996) 3.15
Life expectancy in the Marfan syndrome. Am J Cardiol (1995) 3.14
Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement. J Am Coll Cardiol (1999) 2.98
Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res (1971) 2.95
Real-time radionuclide cineangiography in the noninvasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary-artery disease. N Engl J Med (1977) 2.94
Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines. Am J Hypertens (1994) 2.91
The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature. Am J Med (1979) 2.86
Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med (1999) 2.74
Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol (1995) 2.74
Detection of renovascular hypertension. State of the art: 1992. Ann Intern Med (1992) 2.72
Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol (1984) 2.64
Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med (1994) 2.62
Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med (2000) 2.62
Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol (2001) 2.57
The heart in hypertension. N Engl J Med (1992) 2.53
Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation (1994) 2.50
Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol (1985) 2.50
All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988. The Strong Heart Study. Am J Epidemiol (1998) 2.43
Prognostic implications of left ventricular hypertrophy. Am Heart J (2001) 2.42
Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med (1986) 2.36
Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension (1994) 2.35
Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients. Prog Cardiovasc Dis (1979) 2.29
Residential segregation and mortality in New York City. Soc Sci Med (1998) 2.26
Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension (2001) 2.24
Hyperuricemia in primary and renal hypertension. N Engl J Med (1966) 2.22
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care (2000) 2.22
Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators. Circulation (1998) 2.14
Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med (1972) 2.10
Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. Circulation (2000) 2.10
European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens (2010) 2.06
Mitral valve prolapse. Circulation (1976) 2.05
Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med (1986) 2.04
Universal recommendations for sodium intake should be avoided. Med J Aust (1999) 2.01
Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients. Am J Med (1976) 1.98
Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol (1992) 1.98
Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension (1987) 1.97
Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The International Marfan Syndrome Collaborative Study. N Engl J Med (1992) 1.95
Association between ambulatory blood pressure and alternative formulations of job strain. Scand J Work Environ Health (1994) 1.94
Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol (1995) 1.90
The renin system: Variations in man measured by radioimmunoassay or bioassay. Kidney Int (1972) 1.87
Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest (1986) 1.84
Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade. N Engl J Med (1979) 1.83
Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med (1973) 1.82
An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. N Engl J Med (1974) 1.82
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation (1999) 1.82
Amiloride. A potassium-sparing natriuretic agent. Circulation (1968) 1.80
Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves. J Am Coll Cardiol (1992) 1.78
Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure. Lancet (1973) 1.78
Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. Circulation (1998) 1.77
Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med (1984) 1.76
Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med (1985) 1.75
Job strain and health behaviors: results of a prospective study. Am J Health Promot (1998) 1.75
Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. Am J Med (1981) 1.75
Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS (1988) 1.75
Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation (1990) 1.72
Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study. Am Heart J (1983) 1.72
Effects of autonomic blockade on the baroreflex in man at rest and during exercise. Circ Res (1972) 1.71
Home blood pressure monitoring. Arch Intern Med (2000) 1.71
Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study. JAMA (1991) 1.70
Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation (2001) 1.69
High blood pressure diagnosis and treatment: consensus recommendations vs actual practice. Am J Public Health (1981) 1.68
Blood pressure during normal daily activities, sleep, and exercise. Comparison of values in normal and hypertensive subjects. JAMA (1982) 1.68